Home/Hedge Fund Intelligence/Silence Therapeutics plc
Nasdaq: SLNStockForm 13F30 Jun 2026

Hedge funds that hold Silence Therapeutics plc ADS Nasdaq: SLN

ADS · CUSIP 82686Q101 · who reports it, how much, and how much it matters to them

15 of the 720 hedge fund managers we track reported shares of Silence Therapeutics plc (Nasdaq: SLN) on Form 13F for 30 June 2026. Between them they reported USD 70m. The largest position belongs to Redmile Group, at USD 24m. The manager with the most riding on it is M28 Capital Management, where it is 2.4% of the reported book.

Managers reporting it15of 720 we track
Value they reportUSD 70mshares only, 30 Jun 2026
Funds they run265with a file on PPLI.com
Largest positionUSD 24mRedmile Group
Typical weight0.0%median share of a manager's book
Heaviest weight2.4%M28 Capital Management

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

15 managers, USD 70m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Silence Therapeutics plc, largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Redmile Group10 funds on PPLI.comUSD 24m1.6%
2Citadel Advisors32 funds on PPLI.comUSD 15m0.0%
3Millennium Management6 funds on PPLI.comUSD 10m0.0%
4Balyasny Asset Management25 funds on PPLI.comUSD 6.7m0.0%
5Great Point Partners2 funds on PPLI.comUSD 4.9m0.9%
6Schonfeld Strategic Advisors30 funds on PPLI.comUSD 3m0.0%
7Boothbay Fund Management2 funds on PPLI.comUSD 2.2m0.0%
8Two Sigma Investments35 funds on PPLI.comUSD 1.3m0.0%
9Squarepoint Ops7 funds on PPLI.comUSD 1.3m0.0%
10M28 Capital Management1 fund on PPLI.comUSD 1.1m2.4%
11Marshall Wace LLP84 funds on PPLI.comUSD 791,0000.0%
12Verdad Advisers6 funds on PPLI.comUSD 224,0000.2%
13Scientech Research2 funds on PPLI.comUSD 210,0000.2%
14Renaissance Technologies13 funds on PPLI.comUSD 186,0000.0%
15Persistent Asset Partners10 funds on PPLI.comUSD 167,0000.1%
Next: where it matters most
Where it matters most

For M28 Capital Management it is 2.4% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1M28 Capital ManagementUSD 1.1m2.4%
2Redmile GroupUSD 24m1.6%
3Great Point PartnersUSD 4.9m0.9%
4Verdad AdvisersUSD 224,0000.2%
5Scientech ResearchUSD 210,0000.2%
6Persistent Asset PartnersUSD 167,0000.1%
7Boothbay Fund ManagementUSD 2.2m0.0%
8Schonfeld Strategic AdvisorsUSD 3m0.0%
9Balyasny Asset ManagementUSD 6.7m0.0%
10Millennium ManagementUSD 10m0.0%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Silence Therapeutics plc

What is the ticker symbol of Silence Therapeutics plc?

Silence Therapeutics plc trades under the symbol SLN on the Nasdaq. Its CUSIP, the code used on Form 13F, is 82686Q101.

Which hedge funds own Silence Therapeutics plc (Nasdaq: SLN)?

15 of the 720 hedge fund managers PPLI.com tracks reported Silence Therapeutics plc shares on Form 13F for 30 June 2026. The largest reported positions were held by Redmile Group (USD 24m), Citadel Advisors (USD 15m), Millennium Management (USD 10m), Balyasny Asset Management (USD 6.7m) and Great Point Partners (USD 4.9m).

How many hedge funds hold Silence Therapeutics plc?

15 managers in our coverage reported it, and between them they run 265 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Silence Therapeutics plc?

M28 Capital Management, where the position was 2.4% of the reported 13F book at 30 June 2026.

Does this show who is short Silence Therapeutics plc?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Silence Therapeutics plc or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.